Sceintific Programme 2025

DownloadDownload

10th to 11th October, 2025 

PROGRAMME SCHEDULE

 

DAY-1: Friday, 10th October, 2025

08:00 to 9:00 AM REGISTRA ON/ WELCOME TEA
09:00 to 09:05 AM

09:05 to 09:20 AM

09:20 to 09:25 AM

09:25 to 09:30 AM

·         Prayer by Chaplain

·         Welcome remarks: Director, CMC / Director, inStem / Principal, CMC

·         Remarks by Secretary, Department of Biotechnology, Ministry of Science and Technology, Govt. of India

·         Closing remarks: Head, CSCR

Hall A
Session:  ORGANOIDS AND DISEASE MODELLING
India Time Speaker Title
9.30 to 10:00 AM Maneesha S. Inamdar

Stem Cell Science and Regenerative Medicine (inStem) Bangalore, India

TBC
10:00 to 10:30 AM Ruchi Tandon

Translational Health Science and Technology Institute (THSTI), Faridabad,India

Harnessing the potential of  human liver organoid developed from cells isolated from healthy individuals and patients to develop therapeutics and precision medicines against non-alcoholic fatty liver disease.
10:30 to 11:00 AM Indumathi Mariappan

L V Prasad Eye Institute (LVPEI), Hyderabad, India

Stem cell derived organoid models to study eye diseases and to validate newer drugs
11:00 to 11:30 AM Arvind Ramanathan

Institute for Stem Cell Science and Regenerative Medicine (inStem), Bangalore, India

TBC
 11:30 AM to 12:30 PM Lunch Break
  Hall A   Hall B
India Time Session: MOLECULAR GENETICS OF INHERITED DISEASES

 

India Time Session:  MESENCHYMAL STEM CELLS (MSCs) AND THEIR SECRETOME

 

12:30 to 1:00 PM Sumita Danda

Christian Medical College Vellore, India

12.30 to 1:00 PM Jyothi Prasanna S

Manipal Institute of Regenerative Medicine, Bengaluru, India

1:00 to 1:30 PM Sridhar Sivasubbu

Vishwanath Cancer Care Foundation, India

1:00 to 1:30 PM Ilyas Khan

Swansea University,

Wales, United Kingdom

1:30 to 2:30 PM  Aaron Chapla

Christian Medical College Vellore,

Vellore, India

1:30 to 2:00 PM Potential of Wharton’s Jelly Mesenchymal Stem Cell-Derived Small Extracellular Vesicles in Managing Metabolic Syndrome in an Animal Model

Yogeswaran Lokanathan

Universiti Kebangsaan Malaysia,

Kuala Lumpur, Malaysia

2:30 to 3:00 PM Mission program in pediatric rare genetic disorders

Ashwin Dalal

Centre for DNA Fingerprinting and Diagnostics (CDFD),

Hyderabad, India

2:00 to 2:30 PM Poster presentation and Industry Exhibition
3:00 to 3:30 PM Break  
  Hall A   Hall B
India Time Session:  POPULATION SCREENING & MANAGEMENT OF GENETIC DISORDERS

 

India Time SESSION: CELL AND GENE THERAPY
3:30  to 4:00 PM Sickle Cell Anaemia: Kal, Aaj, aur Kal (Past, Present and Future)

Giriraj Chandak

Centre for Cellular and Molecular Biology Hyderabad, India

2:30 to 3:00 PM Vikram Mathews

Christian Medical College Vellore, India

4:00 to 4:30 PM  Sukesh C Nair

Christian Medical College Vellore, India

3:00 to 3:30 PM Shaji RV

Centre For Stem Cell Research (a Unit of inStem, Bengaluru),

Christian Medical College Vellore, India

4:30 to 5:00 PM Rekha Pai

Christian Medical College Vellore, India

3:30 to 4:00 PM Islet cell transplant in general or anything specific or GMP for islet cell process

Balamurugan N Appakalai

University of Louisville, USA

5:00 to 5:30 PM Vinod Scaria

Karkinos Healthcare Private Limited, Bengaluru, India

4:00 to 4:30 PM Orthobiologics: Injectable Therapies for the Musculoskeletal System

 

Elizabeth Vinod

Centre For Stem Cell Research (a Unit of inStem, Bengaluru),

Christian Medical College Vellore, India

Hall B
Session-3: MANUFACTURING AND REGULATORY ASPECTS IN CELL AND GENE THERAPY
India Time Speaker Name Title
4:30 to 5:00 PM Jonathan Yen

St. Jude Children’s Research Hospital,

Memphis, TN

TBC
5:00 to 5:30 PM Bruce L. Levine

University of Pennsylvania,

Philadelphia, PA

What No T Cell Has Treated Before: Advances in CAR Design and Delivery to Patients
5:30 to 6:00 PM Priyadarshini Chatterjee

Aurigene Oncology Ltd., Bangalore

Robust Manufacturing of NK cells towards development of Allogeneic Therapies
KEYNOTE ADDRESS
India Time Speaker Name Title
6:00 to 6:40 PM Mitchell Weiss

St. Jude Children’s Research Hospital, Memphis, USA

Gene Therapy for Hemoglobinopathies: Recent Developments and Ongoing Challenges
End of Day-1

DAY-2: Saturday 11th October, 2025

Hall A
Session:  CELL THERAPY FOR HEMATOLOGICAL MALIGNANCY
India Time Speaker Title
9.00 to 9:30 AM Biju George

Christian Medical College Vellore, India

TBC
9:30 to 10:00 AM Aby Abraham

Christian Medical College Vellore, India

TBC
10:00 to 10:30 AM Mohankumar K M.

Centre For Stem Cell Research (a Unit of Instem, Bengaluru),

Christian Medical College Vellore, India

TBC
10:00 to 10:30 AM Gene-Edited Allogeneic CAR-T Cells for B-Cell Malignancies

Thiyagaraj M

Centre For Stem Cell Research (a Unit of Instem, Bengaluru),

Christian Medical College Vellore, India

TBC
10:30 to 11:00 AM Break
  Hall A   Hall B
India Time Session: MICROBIAL INFECTIONS CHALLANGES WAY FORWARD India Time Session: SCIENTIFIC PROGRESS FROM PHARMA
11:00 to 11:30 AM Balaji Veeraraghavan

Christian Medical College Vellore, India

12:30 to 1:00 PM Jitendra Vyas

Micro Crispr Pvt. Ltd.

Vapi, Gujarat, India

11:30 to 12:00 PM Sitara Swarna Rao Ajjampur

Christian Medical College VelloreVellore, India

1:00 to 1:30 PM AI-Guided and Metabolically Reprogrammed CAR T Cells for Durable Anti-Tumor Immunity

Tanveer Ahmad

Jamia Milia Islamia,

New Delhi, India

12:00 to 12:30 PM Joy Sarojini Michael

Christian Medical College Vellore, India

1:30 to 2:00 PM MSCs in the clinic – current status & future prospects

Pawan K Gupta

Stempeutics Research, Bangalore, India

12:30 to 1:00 PM From HIV Biology to lentiviral vectors: Insights into the mechanisms of antiviral actions

Ajit Chande

Indian Institute of Science Education and Research ,

Bhopal, India

01:00 to 01:30 PM Lunch Break  
  Hall A   Hall B
India Time Session: TECHNOLOGY ADVANCES

 

India Time SESSION: GENE EDITING
1:30 to 2:00 PM Praveen K Vemula

Stem Cell Science and Regenerative Medicine(inStem) Bangalore, India

2:00 to 2:30 PM Tan Meng How

Nanyang Technological University, Singapore

2:00 to 2:30 PM Sunil Laxman

Stem Cell Science and Regenerative Medicine (inStem) Bangalore, India

2:30 to 3:00 PM Use of precision editing, PROTACs to investigate mechanism of neurodevelopmental disorders

Pradeepa Madapura

Queen Mary University of London, London, UK

2:30 to 3:00 PM Dasaradhi Palakodeti

Stem Cell Science and Regenerative Medicine (inStem) Bangalore, India

3:00 to 3:30 PM Manish Jaiswal

Tata Institute of Fundamental Research, Hyderabad, India

3:00 to 3:30 PM Dhandapany Perundurai

Stem Cell Science and Regenerative Medicine (inStem) Bangalore, India

3:30 to 4:00 PM Break
3:30 to 4:00 PM Break
  Hall A   Hall B
India Time Session:  METABOLIC DISORDERS AND NOVEL THERAPEUTIC STRATEGIES India Time Session:  New Frontier Of Cell Therapy

 

4:00 to 4:30 PM Nihal Thomas

Christian Medical College Vellore, India

4:00 to 4:30 PM CAR T-cell immunotherapy of NKG2D-expressing solid tumours

John Maher

King’s College,

London, UK

4:30 to 5:00 PM Ullas Kothur-Seetharam

Centre for DNA Fingerprinting and

Diagnostics (CDFD), Hyderabad, India

4:30 to 5:00 PM Configuring Chimeric Antigen Receptors for safety and efficacy 

Sunil Martin

BRIC-Rajiv Gandhi Centre for Biotechnology,

Kerala, India

5:00 to 5:30 PM Boosting anti-cancer vaccine by “FORTY” fying immunity to achieve tumor free survival

Jayanta Bhattacharyya
Indian Institute of Technology Delhi, New Delhi, India

5:00 to 5:30 PM Akshay Sharma

St. Jude Children’s Research Hospital,

Memphis, USA

Hall B
Session-7: ADVANCES IN DELIVERY VECTORS
India Time Speaker Title
6:00 to 6:30 PM Sivaprakash K Ramalingam

Indian Institute of Technology,

Kanpur, India

TBC
6:30 to 7:00 PM Saravanabhavan Thangavel

Centre For Stem Cell Research

(a Unit of Instem, Bengaluru),

Christian Medical College Vellore, India

TBC
7:00 to 7:30 PM  Timothy Henrich

University of California San Francisco, San Francisco, CA

TBC
End of Day-2